Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10644824 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature